Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Author(s) Datesort ascending Article Title Journal

Deborah Plana, Geoffrey Fell, Brian M. Alexander, Adam C. Palmer & Peter K. Sorger 

 February 2022 Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects Nature Communications

Liling Huang , Shiyu Jiang  & Yuankai Shi 

 February 2022 Prognostic significance of baseline neutrophil–lymphocyte ratio in patients with non-small-cell lung cancer: a pooled analysis of open phase III clinical trial data futuremedicine

Yu, Peter MD, ET AL

 February 2022 Artificial Intelligence Comes of Age in the Fight Against Cancer Oncology Times

Fadi S.Dahdaleh, Scott K.Sherman, Hunter D.D.Witmer, Ankit Dhiman, Rahul Rajeev, Elizabeth C.Poli, Fabian M.Johnston, Kiran K.Turagaa

 January 2022 Potential evidence of peritoneal recurrence in Stage-II colon cancer from the control arm of CALGB9581 The American Journal of Surgery

Sophia Z Shalhout, Farees Saqlain, Kayla Wright, Oladayo Akinyemi, David M Miller

 January 2022 Generalizable EHR-R-REDCap pipeline for a national multi-institutional rare tumor patient registry Jamia Open

Xiang Yin, Pallavi S. Mishra-Kalyan, Rajeshwari Sridhara, Mark D. Stewart,Elizabeth A. Stuart, and Ruthanna C. Davi

 January 2022 Exploring the Potential of External Control Arms created from Patient Level Data: A case study in non-small cell lung cancer Journal of Biopharmaceutical Statistics

Kirill Zhudenkov, Sergey Gavrilov, Alina Sofronova, Oleg Stepanov, Nataliya Kudryashova, Gabriel Helmlinger, Kirill Peskov

 January 2022 A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics ASCPT

Jie Zhou, Xun Jiang, Hong Amy Xia, Peng Wei, Brian P. Hobbs

 December 2021 Predicting outcomes of phase III oncology trials with Bayesian mediation modeling of tumor response Statistics in Medicine

Shiyu Jiang, Liling Huang, Hongnan Zhen, Peijie Jin, Jing Wang & Zhihuang Hu 

 December 2021 Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis BMC Cancer

Anne A. Eaton, Emily C. Zabor

 December 2021 Analysis of composite endpoints with component-wise censoring in the presence of differential visit schedules Statistics in Medicine

Leeann B Burton, Mahsa Eskian, Amanda C Guidon, Kerry L Reynolds

 November 2021 A review of neurotoxicities associated with immunotherapy and a framework for evaluation Neuro-Oncology Advances

Giorgos Bakoyannis, Dipankar Bandyopadhyay

 November 2021 Nonparametric tests for multistate processes with clustered data AISM

Fionán Donohoea, Yvonne O'Mearaa, AidinRoberts, Louise Comerford, Catherine M. Kelly, JaniceM. Walshe, Michelle Peate, Marth aHickey, Donal J.Brennan

 November 2021 The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer – Trial protocol of a phase II study Contemporary Clinical Trials Communications

Ran Zeng, Fang Liu, Chen Fang, Jin Yang, Lifeng Luo, Ping Yue, Beili Gao, Yuchao Dong, and Yi Xiang

 October 2021 PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients Frontiers in Immunology

Pages